Management and Treatment of Patients With Cirrhosis and Portal Hypertension: Recommendations From the Department of Veterans Affairs Hepatitis C Resource Center Program and the National Hepatitis C Program

被引:177
|
作者
Garcia-Tsao, Guadalupe [1 ,2 ]
Lim, Joseph [1 ,2 ]
机构
[1] Dept Vet Affairs Med Ctr, West Haven, CT USA
[2] Yale Univ, New Haven, CT USA
来源
AMERICAN JOURNAL OF GASTROENTEROLOGY | 2009年 / 104卷 / 07期
关键词
SPONTANEOUS BACTERIAL PERITONITIS; INTRAHEPATIC PORTOSYSTEMIC SHUNT; RANDOMIZED CONTROLLED-TRIAL; INDUCED CIRCULATORY DYSFUNCTION; ENDOSCOPIC VARICEAL LIGATION; PROPRANOLOL PLUS ISOSORBIDE-5-MONONITRATE; EXTRACORPOREAL ALBUMIN DIALYSIS; VASOPRESSIN RECEPTOR ANTAGONIST; PRETRANSPLANT RENAL-FUNCTION; TYPE-1; HEPATORENAL-SYNDROME;
D O I
10.1038/ajg.2009.191
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Cirrhosis represents the end stage of any chronic liver disease. Hepatitis C and alcohol are currently the main causes of cirrhosis in the United States. Although initially cirrhosis is compensated, it eventually becomes decompensated, as defined by the presence of ascites, variceal hemorrhage, encephalopathy, and/or jaundice. These management recommendations are divided according to the status, compensated or decompensated, of the cirrhotic patient, with a separate section for the screening, diagnosis, and management of hepatocellular carcinoma (HCC), as this applies to patients with both compensated and decompensated cirrhosis. In the compensated patient, the main objective is to prevent variceal hemorrhage and any practice that could lead to decompensation. In the decompensated patient, acute variceal hemorrhage and spontaneous bacterial peritonitis are severe complications that require hospitalization. Hepatorenal syndrome is also a severe complication of cirrhosis but one that usually occurs in patients who are already in the hospital and, as it represents an extreme of the hemodynamic alterations that lead to ascites formation, it is placed under treatment of ascites. Recent advances in the pathophysiology of the complications of cirrhosis have allowed for a more rational management of cirrhosis and also for the stratification of patients into different risk groups that require different management. These recommendations are based on evidence in the literature, mainly from randomized clinical trials and meta-analyses of these trials. When few or no data exist from well-designed prospective trials, emphasis is given to results from large series and consensus conferences with involvement of recognized experts. A rational management of cirrhosis will result in improvements in quality of life, treatment adherence, and, ultimately, in outcomes.
引用
收藏
页码:1802 / 1829
页数:28
相关论文
共 50 条
  • [1] Management and treatment of hepatitis C viral infection: Recommendations from the department of veterans affairs hepatitis C resource center program and the national hepatitis C program office
    Yee, Helen S.
    Currie, Sue L.
    Darling, Jama M.
    Wright, Teresa L.
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2006, 101 (10): : 2360 - 2378
  • [2] Update on the Management and Treatment of Hepatitis C Virus Infection: Recommendations from the Department of Veterans Affairs Hepatitis C Resource Center Program and the National Hepatitis C Program Office
    Yee, Helen S.
    Chang, Michael F.
    Pocha, Christine
    Lim, Joseph
    Ross, David
    Morgan, Timothy R.
    Monto, Alexander
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2012, 107 (05): : 669 - 689
  • [3] Management and treatment of hepatitis C virus infection in HIV-infected adults: Recommendations from the Veterans Affairs Hepatitis C Resource Center Program and National Hepatitis C Program Office
    Burgess, J
    Davey, V
    Raab, C
    Deyton, LR
    Wright, TL
    Ho, SB
    Garcia-Tsao, G
    Dominitz, J
    Tien, PC
    Lampiris, H
    Jensen, P
    Currie, S
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2005, 100 (10): : 2338 - 2354
  • [5] Treatment of veterans with hepatitis C in the United States Department of Veterans Affairs
    Ross, David
    JOURNAL OF HEPATOLOGY, 2013, 59 (01) : 196 - 196
  • [6] Reply to: "Treatment of veterans with hepatitis C in the United States Department of Veterans Affairs"
    Cecil, Bennet
    JOURNAL OF HEPATOLOGY, 2013, 59 (01) : 197 - 197
  • [7] National hepatitis C surveillance day in the Veterans Health Administration of the Department of Veterans Affairs
    Roselle, GA
    Danko, LH
    Kralovic, SM
    Simbartl, LA
    Kizer, KW
    MILITARY MEDICINE, 2002, 167 (09) : 756 - 759
  • [8] The Outcome of Hepatitis C Treatment at an Urban Veterans Affairs Medical Center
    Nasser, Eiad
    Pomakov, Ognian
    Hallman, Jason
    Yacoub, Rabi
    Mehboob, Shahid
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2011, 106 : S119 - S119
  • [9] Prescribing practices for the treatment of hepatitis C in a Veterans Affairs medical center
    Mangin, EFM
    Jones, WN
    AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY, 2004, 61 (14) : 1479 - 1482
  • [10] User experience of a hepatitis c population management dashboard in the Department of Veterans Affairs
    Yakovchenko, Vera
    Jacob, David A.
    Rogal, Shari S.
    Morgan, Timothy R.
    Rozenberg-Ben-Dror, Karine
    PLOS ONE, 2023, 18 (05):